Lung Disease

HSCI Executive Committee member Carla Kim is a recipient of the Lung Cancer Discovery Award from the American Lung Association. The award recognizes Kim’s innovative lung cancer research that has the potential to improve patient care and help save lives....

HSCI Principal Faculty member Jose Ordovas-Montanes has received an early-career award from the New York Stem Cell Foundation (NYSCF). He has been named a NYSCF – Robertson Investigator, which recognizes cutting-edge research with the potential to...

What makes SARS-CoV-2, the virus behind COVID-19, such a threat? A new study by HSCI researchers pinpoints the likely cell types that the virus infects. Unexpectedly, it also shows that one of the body's main immune defenses against viral infections may...

Two Harvard Stem Cell Institute (HSCI) scientists have been awarded grants by the American Cancer Society, the largest non-profit and non-governmental funding source of cancer research in the U.S. The awards recognize Ya-Chieh Hsu, Ph.D. and Carla Kim, Ph...

Two studies by HSCI scientists advance our understanding of cancer Two new studies by Harvard Stem Cell Institute (HSCI) scientists give important insights into lung and liver cancers, and have potential implications for cancer treatment. Carla Kim, Ph.D...

By Nancy Fleisler ( Boston Children's Hospital) and Javier Barbuzano (Harvard Stem Cell Institute) To stay healthy, our lungs have to maintain two key populations of cells: the alveolar epithelial cells, which make up the little sacs where gas exchange...

Harvard stem cell researchers have shown that it may one day be possible to treat several lung diseases by introducing proteins that direct lung stem cells to grow the specific cell types needed to repair the lung injuries involved in the conditions...

Harvard stem cell researchers at Massachusetts General Hospital (MGH) have taken a critical step toward discovering in the relatively near future a drug to control cystic fibrosis (CF), a fatal lung disease that claims about 500 lives each year, with 1...

HSCI investigators have determined which of the three types of airway cells are primarily responsible for excess mucous production in pulmonary diseases such as asthma, cystic fibrosis, and bronchitis, hastening the day when it may be possible to develop...